The Summit for the Elimination of Hepatitis B and Hepatitis C as Public Health Threats in the United States

 

                                                                        CALL TO ACTION

Overview
In the face of recent developments in hepatitis C treatment, enhanced global solidarity for hepatitis B and hepatitis C elimination goals through the World Health Organization’s (WHO) recently-released Global Health Sector Strategy on Viral Hepatitis (2016-2021), the Centers for Disease Control and Prevention and its partners commissioned the National Academies of Science, Engineering, and Medicine to convene an expert committee on the topic. The committee worked in two phases. In the first report, released in April, 2016, it was determined that hepatitis B and C could be eliminated as public health problems in the United States. The second report, identifies new opportunities for preventing transmission and recommends action steps that will help ensure people are tested, treated, and/or cured of viral hepatitis, eliminating these infections as public health threats for the nation. The CDC Foundation convened a public meeting for various stakeholders to discuss the report and their roles in implementing the committee’s recommendations.

Summit Objectives

  • Reviewed National Academies of Sciences, Engineering, and Medicine goals for the elimination of HBV and HCV as public health threats in the United States and their recommended actions to achieve these goals.
  • Highlighted the prevention, testing, care, and treatment strategies needed to achieve the HBV and HCV elimination goals including addressing HBV and HCV health disparities among marginalized and underserved populations.
  • Reviewed viral hepatitis elimination efforts underway that could be expanded and identify best practices that could be used by programs to reach elimination goals.
  • Fostered collaborations among stakeholders dedicated to achieving HBV and HBC elimination goals for the United States.

Suggested Readings